ACRS Anand Mehra buys $1.5M worth of shares
Nov 21, 2024, 11:32 AM
-33.17%
What does ACRS do
Aclaris Therapeutics, a biopharmaceutical company based in Wayne, Pennsylvania, focuses on developing novel drugs for dermatology and immunology, with key candidates including ATI-1777 and Zunsemetinib. Founded in 2015, it employs 91 staff and utilizes its KINect platform for drug discovery.
Anand Mehra bought 666,666 shares of ACRS on 19 November at $2.25 per share, worth a total of $1.5M. They now own 710,030 ACRS shares, or a 1537% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.